| Tamara Jennifer Wrzesinski, MD | |
|
1092 Madison Ave, Albany, NY 12208-2248 | |
| (518) 525-2445 | |
| Not Available |
| Full Name | Tamara Jennifer Wrzesinski |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1092 Madison Ave, Albany, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003804360 | NPI | - | NPPES |
| 001433036 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 043303 (Connecticut) | Secondary |
| 208000000X | Pediatrics | 260478 (New York) | Primary |
| Entity Name | St Peters Hospital Of The City Of Albany |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518042357 PECOS PAC ID: 2668460072 Enrollment ID: O20040504001301 |
News Archive
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA). These drugs act more quickly, require less laboratory monitoring, and are better tolerated than nonbiologic DMARDs, but they are also up to 100 times more expensive.
Although maintaining good blood sugar control is crucial for avoiding complications of diabetes, it has been estimated that only about half of patients are successful in meeting target blood glucose levels.
COVID-19 is a spreading viral illness, mostly mild but fatal in the sick and elderly. At present, it has affected almost 200,000 people, with nearly 8,000 deaths worldwide. Governments around the world are formulating and executing new guidelines to control the spread of the virus. In the latest guidelines, pregnant women join the list of individuals who must stay away from all social contact for 12 weeks to limit the spread of the virus and deaths due to the illness.
› Verified 3 days ago
| Entity Name | St. Peter's Health Partners Medical Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626834 PECOS PAC ID: 6103061189 Enrollment ID: O20130321000567 |
News Archive
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA). These drugs act more quickly, require less laboratory monitoring, and are better tolerated than nonbiologic DMARDs, but they are also up to 100 times more expensive.
Although maintaining good blood sugar control is crucial for avoiding complications of diabetes, it has been estimated that only about half of patients are successful in meeting target blood glucose levels.
COVID-19 is a spreading viral illness, mostly mild but fatal in the sick and elderly. At present, it has affected almost 200,000 people, with nearly 8,000 deaths worldwide. Governments around the world are formulating and executing new guidelines to control the spread of the virus. In the latest guidelines, pregnant women join the list of individuals who must stay away from all social contact for 12 weeks to limit the spread of the virus and deaths due to the illness.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tamara Jennifer Wrzesinski, MD Po Box 14890, Albany, NY 12212-4890 Ph: () - | Tamara Jennifer Wrzesinski, MD 1092 Madison Ave, Albany, NY 12208-2248 Ph: (518) 525-2445 |
News Archive
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA). These drugs act more quickly, require less laboratory monitoring, and are better tolerated than nonbiologic DMARDs, but they are also up to 100 times more expensive.
Although maintaining good blood sugar control is crucial for avoiding complications of diabetes, it has been estimated that only about half of patients are successful in meeting target blood glucose levels.
COVID-19 is a spreading viral illness, mostly mild but fatal in the sick and elderly. At present, it has affected almost 200,000 people, with nearly 8,000 deaths worldwide. Governments around the world are formulating and executing new guidelines to control the spread of the virus. In the latest guidelines, pregnant women join the list of individuals who must stay away from all social contact for 12 weeks to limit the spread of the virus and deaths due to the illness.
› Verified 3 days ago
Dr. Patricia Marie Hopkins, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-0218 Fax: 518-262-4933 | |
Dr. Kallanna Manjunath, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 920 Lark Dr, Albany, NY 12207 Phone: 518-465-4771 Fax: 518-242-4784 | |
Lisa Benay Kamerling, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1092 Madison Ave, St. Peter's Health Care For Children, Albany, NY 12208 Phone: 518-525-2445 Fax: 518-475-7069 | |
Michael T Colon, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 319 S Manning Blvd, Suite 203, Albany, NY 12208 Phone: 518-489-3292 Fax: 518-453-6286 | |
Sarah Kathleen Klaiber Sokil, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 103 Great Oaks Blvd, Albany, NY 12203 Phone: 518-464-1392 | |
Anita Catherine Saldanha, MD PHD Pediatrics Medicare: Medicare Enrolled Practice Location: 47 New Scotland Ave, Department Of Pediatrics, Albany, NY 12208 Phone: 518-262-3095 |